Author: Customer Service

Production-ready 3DI technology supports more compact FEMs for advanced 5G devices MALTA, N.Y., June 23, 2026 (GLOBE NEWSWIRE) — GlobalFoundries (Nasdaq: GFS) (GF) today announced the production readiness of its SLATE™ wafer-to-wafer bonding technology on its industry-leading 9SW radio-frequency silicon-on-insulator (RF-SOI) platform, delivering advanced 3D integration (3DI) for compact, high-performance cellular front-ends. Manufactured at GF’s 300mm facility in Singapore, 9SW SLATE technology is expected to ramp to volume production by the second half of 2027. GF’s first-generation SLATE technology supports wafer-to-wafer (W2W) bonding, enabling designers to bond two 9SW wafers to stack and integrate large-size field-effect transistors (FETs) in vertical architectures. By folding large FETs across bonded wafers, SLATE...

Enables standardized inpatient hospital billing for QUELIMMUNE® (SCD-PED) therapy Universal code paves the way for billing of future potential SCD therapies requiring renal replacement therapy DENVER, June 23, 2026 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life announced today that its Selective Cytopheretic Device (SCD) therapy has received dedicated ICD-10-PCS (International Classification of Diseases, 10th Revision, Procedure Coding System) codes from the Centers for Medicare & Medicaid Services (CMS). This assignment enables administrative, billing, and statistical reporting for the use of SeaStar Medical’s SCD therapy in patients with acute kidney...

KAYAK survey reveals which football stars Brazilians would take as travel companions and how fans can discover destinations connected to their idols SAO PAULO, June 23, 2026 (GLOBE NEWSWIRE) — KAYAK surveyed 2,000 travellers to find out which football player they’d most want to travel with, and where in Brazil they’d take them. Passport stamped for the Portuguese star Cristiano Ronaldo was chosen by 60% of respondents, followed by Vinícius Júnior (19%) and Endrick (9%). The reasons? 41% cited personal admiration, 23% want to see what goes on behind the scenes of an athlete’s holiday, and 15% want to live a once in a lifetime experience alongside one of football’s biggest names. The Northeast Steals the Show When asked where they’d take their football idol, 59% of Brazilians pointed to the Northeast...

GUANGZHOU, China, June 23, 2026 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading advanced air mobility (“AAM”) technology platform company, announced that it has been selected, together with its partners Kwoon Chung Smart Mobility Co.,Ltd and Hong Kong Cyberport Management Company Limited, as one of the first batch of trial projects under Hong Kong’s “Low-Altitude Economy (“LAE”) Regulatory Sandbox X” initiative for unconventional aircraft applications. All parties will leverage their respective resource advantages to steadily advance compliant demonstration flights, scenario validation and a series of coordinated efforts, contributing to the high‑quality growth of Hong Kong’s low‑altitude economy. As Hong Kong actively rolls out multiple rounds of regulatory sandbox trial projects,...

NORTH PALM BEACH, Fla., June 23, 2026 (GLOBE NEWSWIRE) — SRX Global, Inc. (NYSE American: SRXH) (the “Company”, or “SRX”) today announced a strategic investment in ARMR Sciences, a clinical-stage biodefense company developing a platform of medical countermeasures against synthetic drugs, such as fentanyl. ARMR’s lead product, ARMR-100, recently announced it has successfully generated an anti-fentanyl immune response in humans and showed favorable safety data. This marks a critical milestone in the company’s path toward demonstrating that this response can protect against fentanyl. ARMR-100 is being designed to work with the body to generate a protective immune response. The product, in a Phase 1/2 clinical trial, produces anti-fentanyl antibodies capable of binding to lethal synthetic drugs. Once the antibodies...

MONTREAL, June 23, 2026 (GLOBE NEWSWIRE) — PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health”, or the “Company”) announces proceedings under the Companies’ Creditors Arrangement Act (Canada) (the “CCAA”) have been initiated in respect of the Company and certain of its subsidiaries. The application is scheduled to be presented before the Superior Court of Québec (Commercial Division) today, June 23, 2026. Operations of the Company and its subsidiaries continue without interruption in the ordinary course. About Premier Health Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, companies, and individuals. Premier Health uses its proprietary LiPHe® platform to lead the digital transformation of the healthcare services...

Company Orders Initial AI GPU Hardware, Markets Available Power Capacity to AI Customers, and Sees Potential $20M–$50M Annual Revenue Opportunity Assuming Full Buildout TAMPA, Fla., June 23, 2026 (GLOBE NEWSWIRE) — LM Funding America, Inc. (Nasdaq: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced a strategic expansion into high-performance computing (“HPC”) and artificial intelligence (“AI”) infrastructure. The Company has ordered its initial AI GPU server hardware for this AI-HPC business expansion for deployment at its Oklahoma facility and is actively marketing its available power capacity at both of its facilities to qualified AI co-location and power hosting customers with additional capacity to follow as demand follows. The expansion leverages LM Funding’s 26 megawatts of wholly-owned,...

Positive data supports the continued advancement of FDA Investigational New Drug (IND)- enabling development program SARASOTA, FLA., June 23, 2026 (GLOBE NEWSWIRE) — Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it has confirmed the physical, chemical and microbiological stability of its investigational soft-mist intranasal prophylactic, SPC-15, through nine months of real-time testing. The stability data demonstrates that SPC-15’s formulation maintains physical, chemical, and microbiological integrity over nine months at long term and six months at accelerated conditions. The stability program was conducted under long-term and accelerated storage conditions alignedwith requirements for investigational...

In the first quarter of 2026, carriers returned $6.2 billion to policyholders; casualty lines remained under pressure, but there was continued momentum in personal auto underwriting JERSEY CITY, N.J., June 23, 2026 (GLOBE NEWSWIRE) — Year-over-year, the U.S. property/casualty (P&C) insurance industry’s financial performance improved through the first three months of 2026, according to Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, and the American Property Casualty Insurance Association (APCIA), the primary national trade association for home, auto and business insurers. According to key financial indicators for private U.S. P&C insurers, the industry posted an estimated net underwriting gain of approximately $15.8 billion in Q1 2026, a strong rebound...